Skip to main content

Table 3 Foot health thermometer scores and EQ-5D-3L utility index at baseline, 1 and 3 months

From: Cost-effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton’s neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial)

Outcome measurea (Control n = 55, Steroid n = 54)
  Mean (SD) Mean adjusted for the baseline (SE) Estimated differenceb[95% CI] significance
  Control Steroid Control Steroid
EQ-5D-3L utility index      
 Baseline 0.5831 (0.2947) 0.5346 (0.3023) Not applicable Not applicable Not applicable
 1 month 0.6213 (0.2523) 0.6129 (0.2717) 0.6178 (0.0351) 0.6164 (0.0354) −0.0014 (−0.0976, 0.1004) p = 0.98
 3 months 0.5944 (0.2852) 0.6226 (0.2771) 0.5930 (0.0388) 0.6241 (0.0388) 0.0311 (−0.0780, 0.1403) p = 0.57
QALY 0.1510 (0.0522) 0.1506 (0.0511) 0.1473 (0.0062) 0.1511 (0.0068) 0.0038 (−0.0146, 0.0221) p = 0.68
Foot health thermometer scores      
 Baseline 48.17 (23.68) 45.23 (21.22) Not applicable Not applicable Not applicable
 1 month 49.30 (24.21) 60.28 (22.01) 48.49 (3.07) 60.81 (3.10) 12.32 (3.66, 20.98) p = 0.006
 3 months 53.06 (26.77) 64.26 (22.05) 52.77 (3.36) 64.69 (3.32) 11.92 (2.54, 21.29) p = 0.013
FHT-AUC 12.469 (5.061) 14.738 (4.038) 12.276 (0.504) 14.748 (0.556) 2.472 (0.986, 3.958) p = 0.001
  1. aImputed where necessary.
  2. bIn the final column, positive differences represent a better outcome for participants in the steroid group, and results in bold type are significant at 5% level.